Strong Q3 Results Drive Guardant's Stock 15% Higher In 20 Days

Guardant Health (NASDAQ:GH) offers non-invasive cancer diagnosis tests and is based out of the U.S. The company has seen its stock rally 15% since its Q3 results were announced. The company reported strong results in Q3 with sales growth coming in at $61 Mil - a 181% jump year-on-year...